Fresenius Kabi Oncology - Your Partner in Cancer Care
NEWS
Updates
22.11.2010
BOPA - Manchester 2010
View article…
19.10.2009
BOPA 2009: Oncology gets fabulous feedback for first exhibition.
View article…
Latest Developments
24.11.2010
Clinical Governance Brochure Launched
View article…
17.09.2010
Further Gemcitabine study extends shelf life to 120 days
View article…

Fresenius Kabi delivers on promises

Fresenius Kabi is dedicated to the therapy and care of critically and chronically ill patients in and outside the hospital by providing intravenously administered drugs, infusion therapies, clinical nutrition and related medical devices.

Introducing Fresenius Kabi Oncology

Fresenius Kabi Oncology is one of the most vertically integrated generic oncology companies. Specialising in generic drugs for cancer treatment, we offer an extensive range of products for the common diseases of the lung, breast, and colon cancer, as well as tumors of the neck and head.

Our Oncology Portfolio

With the introduction of our portfolio of generic products, Fresenius Kabi Oncology offers an integrated approach to cancer therapy. Globally this includes IV solutions and drugs, parenteral and enteral nutrition, infusion technology, aseptic compounding services and homecare.

Our presence in the generic oncology market demonstrates our ongoing commitment to offering customers high quality products supported by manufacturing and supply chain expertise.

In the UK, Fresenius Kabi Oncology holds contracts for the supply of a range of licensed oncology products.